Riskpilot← Back to searchSign inGet full accessLOLLAND FYSIOTERAPI ApS
APSActiveCVR 26302889Vejlegade 22-24Physiotherapy activities · NACE 8695Est. 200125 employeeswww.lollandfysioterapi.dk
Revenue 2025
DKK 8M
+1% vs 2024
EBITDA margin
18.3%
-14% vs 2024
Equity ratio
47.9%
Financial strength
Net profit 2025
DKK 852K
-15% vs 2024
| Revenue | DKK 8M | +1% |
| EBITDA | DKK 1,5M | -14% |
| Net profit | DKK 852K | -15% |
| Total assets | DKK 7,4M | +10% |
| Equity | DKK 3,6M | +1% |
| Employees | 25 | — |
Legal name
LOLLAND FYSIOTERAPI ApS
CVR number
26302889
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. november 2001
Share capital
DKK 126.000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive fysioterapi- og motionscentervirksomhed og anden virksomhed, der er naturligt forbundet hermed
Address
Vejlegade 22-24
Phone
+4554921411
Email
info@lollandfysioterapi.dk
Website
www.lollandfysioterapi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.358 | 1.361 | 1.313 | 2.860 | 4.445 | 5.886 | 6.436 | 7.548 | 6.719 | 6.040 | 6.518 | 7.028 | 7.865 | 7.958 |
| Staff expenses | -843 | -1.091 | -890 | -1.979 | -2.941 | -4.078 | -4.242 | -5.362 | -5.002 | -4.464 | -5.088 | -5.252 | -6.175 | -6.500 |
| EBITDA | 515 | 270 | 334 | 881 | 1.504 | 1.807 | 2.194 | 2.186 | 1.716 | 1.575 | 1.430 | 1.776 | 1.690 | 1.458 |
| Depreciation & amort. | 35 | 55 | 249 | -227 | -354 | -361 | -374 | -227 | -224 | -220 | -228 | -224 | -217 | -213 |
| EBIT | 481 | 216 | 85 | 654 | 1.150 | 1.447 | 1.820 | 1.959 | 1.493 | 1.356 | 1.202 | 1.552 | 1.472 | 1.244 |
| Net financials | -71 | -95 | -138 | -243 | -385 | -364 | -235 | -282 | -267 | -261 | -185 | -178 | -182 | -150 |
| Profit before tax | 410 | 120 | -53 | 411 | 765 | 1.083 | 1.585 | 1.677 | 1.226 | 1.095 | 1.017 | 1.373 | 1.290 | 1.095 |
| Tax | 107 | 31 | -20 | 94 | 169 | 239 | 350 | 372 | 273 | 244 | 225 | 302 | 284 | 242 |
| Net profit | 303 | 89 | -32 | 317 | 596 | 844 | 1.236 | 1.305 | 953 | 851 | 792 | 1.071 | 1.006 | 852 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 711 | 1.556 | 1.510 | 6.052 | 6.648 | 6.960 | 7.607 | 8.418 | 8.123 | 7.731 | 6.924 | 7.536 | 6.764 | 7.419 |
| Equity | -153 | -64 | -96 | 222 | 818 | 1.215 | 1.851 | 2.356 | 2.409 | 2.859 | 3.052 | 3.573 | 3.507 | 3.555 |
| Long-term debt | 148 | 1.185 | 1.255 | 5.072 | 4.267 | 4.397 | 4.319 | 3.912 | 3.462 | 2.863 | 2.493 | 2.314 | 1.644 | 1.533 |
| Short-term debt | 705 | 406 | 347 | 712 | 1.028 | 1.294 | 1.380 | 2.060 | 2.159 | 1.913 | 1.287 | 1.563 | 1.529 | 2.264 |
| Total debt | 853 | 1.591 | 1.603 | 5.784 | 4.753 | 5.691 | 5.699 | 5.972 | 5.621 | 4.776 | 3.780 | 3.877 | 3.173 | 3.797 |
EBITDA margin
18.3%
This company
15.8%
Market median
+16% vs market
20122025
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
20122025
Return on equity
24.0%
This company
18.4%
Market median
+30% vs market
20122025
Net profit margin
10.7%
This company
8.1%
Market median
+32% vs market
20122025
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20122025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2001 | — | — |
HU Audit | Audit | 2001 | — | — |
AS Management | Management | 2020 | — | — |
JB Management | Management | 2003 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AMCL HOLDING ApS | Company | 100.0% | 100.0% | 2015 |
ROHA HOLDING ApS | Company | 33.3% | 33.3% | 2015 |
REBIKO HOLDING ApS | Company | 50.0% | 50.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AMCL HOLDING ApS
LOLLAND FYSIOTERAPI ApS Board members of LOLLAND FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Schierbeck | Management | 0 companies |
| Henrik Ulvsgaard | Audit | 0 companies |
| Annemette Stampe Holst | Management | 0 companies |
| Jim Bang Olsen-Kludt | Management | 0 companies |
| Robin Andre Hanssen | Board of Directors | 0 companies |
| Frederikke Victoria Olsen-Kludt | Chairman | 0 companies |